Klotho deficiency aggravates sepsis-related multiple organ dysfunction

Carregando...
Imagem de Miniatura
Citações na Scopus
21
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER PHYSIOLOGICAL SOC
Autores
Citação
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, v.316, n.3, p.F438-F448, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Sepsis-induced organ failure is characterized by a massive inflammatory response and oxidative stress. Acute kidney injury (AKI) occurs in approximately half of patients in septic shock, and the mortality associated with sepsis-induced AKI is unacceptably high. Klotho is a protein expressed by renal cells and has anti-senescence properties. Klotho has also been shown to protect the kidneys in ischemia-reperfusion injury and to have antioxidant properties. To analyze the role of Klotho in sepsis-related organ dysfunction and AKI, we used a cecal ligation and puncture (CLP) model of sepsis in heterozygous Klotho-haploinsufficient mice and their wild-type littermates (CLP-Kl/+ and CLP-WT mice, respectively). In comparison with the CLP-WT mice, CLP-Kl/+ mice showed lower survival, impaired renal function, impaired hepatic function, greater oxidative stress, upregulation of inflammatory pathways (at the systemic and kidney tissue levels), and increased NF-KB activation. It is noteworthy that CLP-Kl/+ mice also showed lower heart-rate variability, less sympathetic activity, impaired baroreflex sensitivity to sodium nitroprussidc, and a blunted blood pressure response to phenylephrine. We also demonstrated that sepsis creates a state of acute Klotho deficiency. Given that low Klotho expression exacerbates sepsis and multiple organ dysfunction. Klotho might play a protective role in sepsis, especially in elderly individuals in whom Klotho expression is naturally reduced.
Palavras-chave
acute kidney injury, autonomic disorder, Klotho, multiple organ dysfunction, sepsis
Referências
  1. Bregere F, 2006, AGEING RES REV, V5, P60, DOI 10.1016/j.arr.2005.09.002
  2. Brivet FG, 1996, CRIT CARE MED, V24, P192, DOI 10.1097/00003246-199602000-00003
  3. Bucher M, 2003, CRIT CARE MED, V31, P566, DOI 10.1097/01.CCM.0000048621.36569.69
  4. CARCILLO JA, 1988, CIRC SHOCK, V26, P331
  5. Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740
  6. Coletta C, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0511-3
  7. Condor JM, 2016, STEM CELL TRANSL MED, V5, P1048, DOI 10.5966/sctm.2015-0138
  8. De Angelis K, 2012, AM J PHYSIOL-REG I, V302, pR950, DOI 10.1152/ajpregu.00450.2011
  9. Doi K, 2008, KIDNEY INT, V73, P1266, DOI 10.1038/ki.2008.97
  10. Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037
  11. Duman A, 2016, AM J EMERG MED, V34, P2167, DOI 10.1016/j.ajem.2016.06.012
  12. FLORAS JS, 1988, J HYPERTENS, V6, P525, DOI 10.1097/00004872-198807000-00003
  13. Garrard C S, 1993, Clin Auton Res, V3, P5, DOI 10.1007/BF01819137
  14. Glezer I, 2003, NEUROPHARMACOLOGY, V45, P1120, DOI 10.1016/S0028-3908(03)00279-X
  15. Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052
  16. Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
  17. Holly MK, 2006, KIDNEY INT, V70, P496, DOI 10.1038/sj.ki.5001575
  18. Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333
  19. Hu MC, 2017, KIDNEY INT, V91, P1104, DOI 10.1016/j.kint.2016.10.034
  20. Hu MC, 2012, NEPHROL DIAL TRANSPL, V27, P2650, DOI 10.1093/ndt/gfs160
  21. Hu MC, 2012, NAT REV NEPHROL, V8, P423, DOI 10.1038/nrneph.2012.92
  22. Hu MC, 2010, J NEPHROL, V23, pS136
  23. Hu MC, 2010, KIDNEY INT, V78, P1240, DOI 10.1038/ki.2010.328
  24. Inoue S, 2013, SHOCK, V39, P311, DOI 10.1097/SHK.0b013e3182845445
  25. John GB, 2011, AM J KIDNEY DIS, V58, P127, DOI 10.1053/j.ajkd.2010.12.027
  26. Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052
  27. Korhonen P, 1997, NEUROSCI LETT, V225, P61, DOI 10.1016/S0304-3940(97)00190-0
  28. Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028
  29. Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005
  30. Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
  31. Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766
  32. Langenberg C, 2008, CRIT CARE, V12, DOI 10.1186/cc6823
  33. Lee SY, 2012, CRIT CARE MED, V40, P2997, DOI 10.1097/CCM.0b013e31825b912d
  34. Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc
  35. Lopes JA, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-9
  36. Maekawa Y, 2009, ENDOCRINE, V35, P341, DOI 10.1007/s12020-009-9181-3
  37. Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139
  38. Matsuda N, 2006, J PHARMACOL EXP THER, V319, P1348, DOI 10.1124/jpet.106.109785
  39. Miyaji T, 2003, KIDNEY INT, V64, P1620, DOI 10.1046/j.1523-1755.2003.00268.x
  40. Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073
  41. Nabeshima Y, 2002, AGEING RES REV, V1, P627, DOI 10.1016/S1568-1637(02)00027-2
  42. NATH KA, 1990, J CLIN INVEST, V86, P1179, DOI 10.1172/JCI114824
  43. Neild Guy H., 2001, International Urology and Nephrology, V32, P559, DOI 10.1023/A:1014474305423
  44. Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967
  45. PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178
  46. Pettila V, 2014, INTENS CARE MED, V40, P1018, DOI 10.1007/s00134-014-3313-9
  47. Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523
  48. Rotondi S, 2015, INT J ENDOCRINOL, DOI 10.1155/2015/872193
  49. SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
  50. Sharshar T, 2003, LANCET, V362, P1799, DOI 10.1016/S0140-6736(03)14899-4
  51. Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165
  52. Sugiura H, 2011, CLIN EXP NEPHROL, V15, P795, DOI 10.1007/s10157-011-0511-4
  53. Takeshita K, 2004, CIRCULATION, V109, P1776, DOI 10.1161/01.CIR.0000124224.48962.32
  54. Teixeira C, 2013, CRIT CARE, V17, DOI 10.1186/cc12484
  55. Tilstra JS, 2011, AGING DIS, V2, P449
  56. Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813
  57. Vogt BL, 2007, BIOCHEM PHARMACOL, V73, P1613, DOI 10.1016/j.bcp.2007.01.033
  58. Zamo FS, 2010, CLINICS, V65, P85, DOI 10.1590/S1807-59322010000100013